Jiyeong lee

Jiyeong lee


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2018 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
APArup Podder
Arup Podder
SKSeyoung Koo
Seyoung Koo
JLJiyeong lee
Jiyeong lee
SMSora Mun
Sora Mun
SKSabina Khatun
Sabina Khatun
Jong Seung KimJong Seung Kim
Jong Seung Kim
Herein, we report a rhodamine-based redox probe (MQR) to visualize cytosolic NADH in the cellular milieu. Its high sensitivity and selectivity allowed it to track the alteration of the NADH level under metabolic perturbation, suggesting its potential as a useful tool to study the association between the NADH level and metabolic abnormalities with clinical significance.

Verified
Journal Article
Open access
PDF file
SMSora Mun
Sora Mun
JLJiyeong lee
Jiyeong lee
APArum Park
Arum Park
HKHyo-Jin Kim
Hyo-Jin Kim
YLYoo-Jin Lee
Yoo-Jin Lee
HKHee-Gyoo Kang
Hee-Gyoo Kang
Rheumatoid arthritis is an autoimmune disease that causes serious functional loss in patients. Early and accurate diagnosis of rheumatoid arthritis may attenuate its severity. Despite a diagnosis guideline in the 2010 American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR) classification criteria for rheumatoid arthritis, the practical difficulties in its diagnosis highlight the need of developing new methods for diagnosing rheumatoid arthritis. The current study aimed to identify rheumatoid arthritis diagnostic biomarkers by using a proteomics approach. Serum protein profiling was conducted using mass spectrometry, and five distinguishable biomarkers were identified therefrom. In the validation study, the five biomarkers were quantitatively verified by multiple reaction monitoring (MRM) analysis. Two proteins, namely serum amyloid A4 and vitamin D binding protein, showed high performance in distinguishing patients with rheumatoid arthritis from healthy controls. Logistic analysis was conducted to evaluate how accurately the two biomarkers distinguish patients with rheumatoid arthritis from healthy controls. The classification accuracy was 86.0% and 81.4% in patients with rheumatoid arthritis and in healthy controls, respectively. Serum amyloid A4 and vitamin D binding protein could be potential biomarkers related to the inflammatory response and joint destruction that accompany rheumatoid arthritis.

15 December 2017 in Nutrients
Verified
Journal Article
Open access
PDF file
JLJiyeong lee
Jiyeong lee
APArum Park
Arum Park
MKMi Jeong Kim
Mi Jeong Kim
HLHee-Joung Lim
Hee-Joung Lim
YRYoung-Ah Rha
Young-Ah Rha
HKHee-Gyoo Kang
Hee-Gyoo Kang
Interest in the nutritional value and pharmacological activities of blue-green algae has gradually increased. Spirulina extracts show protective effects against apoptosis and inflammatory damage in various cell types. Here, we investigated the protective effects of extracts from Spirulina maxima in a cytokine-mediated type 1 diabetes model in vitro and in streptozotocin-induced diabetic Wistar rats in vivo. Interleukin-1β and interferon-gamma induced substantial cytotoxicity to RINm5F rat insulinoma cells, increasing nitric oxide (NO) production, nuclear factor-kappa B (NF-κB) activity, the expression of endoplasmic reticulum (ER) stress genes, and activation of mitogen-activated protein kinases and key genes related apoptosis. However, the cytotoxicity of cytokines was significantly attenuated by Spirulina extract, which effectively prevented NO production by inhibiting the synthesis of cytokine-activated NO synthase (iNOS), and apoptosis was suppressed. These results suggest that Spirulina extract might be effective to preserve the viability and function of pancreatic β-cells against cytotoxic conditions. Moreover, diabetic mice orally administered Spirulina extract showed decreased glucose levels, increased insulin, and improvement in liver enzyme markers. The antioxidant effect of Spirulina extract may be helpful in treating type 1 diabetes by enhancing the survival, and reducing or delaying cytokine-mediated β-cells destruction.

1 July 2021 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
HCHyebin Choi
Hyebin Choi
SMSora Mun
Sora Mun
EJEun-Jeong Joo
Eun-Jeong Joo
KLKyu Young Lee
Kyu Young Lee
HKHee-Gyoo Kang
Hee-Gyoo Kang
JLJiyeong lee
Jiyeong lee

26 August 2020 in International Journal of Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
YLYoo‐Jin Lee
Yoo‐Jin Lee
SMSora Mun
Sora Mun
YLYou‐Rim Lee
You‐Rim Lee
SLSeungyeon Lee
Seungyeon Lee
SKSohyen Kwon
Sohyen Kwon
JLJiyeong lee
Jiyeong lee

4 June 2021 in Bioscience Reports
Verified
Journal Article
Open access
PDF file
MSMiji Shin
Miji Shin
SMSora Mun
Sora Mun
SPSang Hyun Park
Sang Hyun Park
JLJiyeong lee
Jiyeong lee
HKHee-Gyoo Kang
Hee-Gyoo Kang
Acute coronary syndrome (ACS) results from inadequate supply of blood flow from the coronary arteries to the heart or ischemia. ACS has an extremely high morbidity and mortality. The levels of biomarkers currently used for detection of ACS also increase in response to myocardial necrosis and other diseases and are not elevated immediately after symptoms appear, thus limiting their diagnostic capacity. Therefore, we aimed to discover new ACS diagnostic biomarkers with high sensitivity and specificity that are specifically related to ACS pathogenesis. Sera from 50 patients with ACS and healthy controls (discovery cohort) each were analyzed using mass spectrometry (MS) to identify differentially expressed proteins, and protein candidates were evaluated as ACS biomarkers in 120 people in each group (validation cohort). α-1-acid glycoprotein 1 (AGP1), complement C5 (C5), leucine-rich α-2-glycoprotein (LRG), and vitronectin (VN) were identified as biomarkers whose levels increase and gelsolin (GSN) as a biomarker whose levels decrease in patients with ACS. We concluded that these biomarkers are associated with the pathogenesis of ACS and can predict the onset of ACS prior to the appearance of necrotic biomarkers.